Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Treasury stock	Accumulated other comprehensive loss	Retained earnings
Beginning Balance at Dec. 31, 2021	$ 15,849,248	$ 4,024,561	$ (824,190)	$ (40,495)	$ 12,689,372
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		11,810
Stock-based compensation expense		119,209
Other comprehensive income (loss)				(33,675)
Net income	1,597,447				1,597,447
Ending Balance at Mar. 31, 2022	17,544,039	4,155,580	(824,190)	(74,170)	14,286,819
Beginning Balance at Dec. 31, 2022	20,777,401	4,637,601	(824,190)	(217,306)	17,181,296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		25,695
Stock-based compensation expense		99,099
Repurchases of common stock to be held as treasury stock	(400,000)		(404,730)
Other comprehensive income (loss)				25,611
Net income	1,305,120				1,305,120
Ending Balance at Mar. 31, 2023	$ 21,828,196	$ 4,762,395	$ (1,228,920)	$ (191,695)	$ 18,486,416